Related references
Note: Only part of the references are listed.Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics
H. A. Gefroh-Grimes et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
Dayle Rundle-Thiele et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Prognostic relevance of epilepsy at presentation in glioblastoma patients
Sharon Berendsen et al.
NEURO-ONCOLOGY (2016)
Corticosteroids compromise survival in glioblastoma
Kenneth L. Pitter et al.
BRAIN (2016)
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
Caroline Happold et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide
Navid Redjal et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Seizures and gliomas - towards a single therapeutic approach
Gilles Huberfeld et al.
NATURE REVIEWS NEUROLOGY (2016)
Clinicopathological factors predictive of postoperative seizures in patients with gliomas
Pei Yang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2016)
Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme
Young-Hoon Kim et al.
CANCER (2015)
Prognostic implications of epilepsy in glioblastomas
Manuel Toledo et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2015)
What is New in the Management of Epilepsy in Gliomas?
Roberta Ruda et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2015)
A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma
Andra V. Krauze et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients
Lisa B. E. Shields et al.
RADIATION ONCOLOGY (2015)
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
Stephanie M. Robert et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study
Alexander Tinchon et al.
JOURNAL OF NEUROLOGY (2015)
Changing incidence and improved survival of gliomas
Vincent K. Y. Ho et al.
EUROPEAN JOURNAL OF CANCER (2014)
Seizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management
Charles J. Vecht et al.
ONCOLOGIST (2014)
Survival analysis for valproic acid use in adult glioblastoma multiforme: A meta-analysis of individual patient data and a systematic review
Yang Yuan et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2014)
Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme
Arnulf Mayer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Does the choice of antiepileptic drug have an impact on the survival of glioblastoma multiforme?
Greg Guthrie et al.
BRITISH JOURNAL OF NEUROSURGERY (2013)
Survival of children with malignant brain tumors receiving valproate: a retrospective study
F. H. C. Felix et al.
CHILDS NERVOUS SYSTEM (2013)
Seizure characteristics and prognostic factors of gliomas
Melissa Kerkhof et al.
EPILEPSIA (2013)
Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival
Christopher A. Barker et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme
Anna Rosati et al.
NEURO-ONCOLOGY (2013)
Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme
Melissa Kerkhof et al.
NEURO-ONCOLOGY (2013)
Effect of valproic acid on the outcome of glioblastoma multiforme
Hong-Chieh Tsai et al.
BRITISH JOURNAL OF NEUROSURGERY (2012)
Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results
Sharon Berendsen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Glioblastoma survival in the United States before and during the temozolomide era
Derek R. Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Epilepsy meets cancer: when, why, and what to do about it?
Michael Weller et al.
LANCET ONCOLOGY (2012)
Glutamate is associated with a higher risk of seizures in patients with gliomas
Tanya I. Yuen et al.
NEUROLOGY (2012)
Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population
Cecilie Johannessen Landmark et al.
EPILEPSY RESEARCH (2011)
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
M. Weller et al.
NEUROLOGY (2011)
Antiepileptic drugs for treating seizures in adults with brain tumours
Simon Kerrigan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
R. Helseth et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
Inger Kristin Larsen et al.
EUROPEAN JOURNAL OF CANCER (2009)
Efficacy of anti-epileptic drugs in patients with gliomas and seizures
Melanie S. M. van Breemen et al.
JOURNAL OF NEUROLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma
Kurt A. Jaeckle et al.
NEUROLOGY (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
Melanie S. M. van Breemen et al.
LANCET NEUROLOGY (2007)
Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients
J. -F. Mineo et al.
ACTA NEUROCHIRURGICA (2007)
P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy
S Oberndorfer et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells
P Sur et al.
GLIA (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs
PN Patsalos et al.
LANCET NEUROLOGY (2003)